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OBJECTIVES The goal of this study was to examine the relationship between alcohol intake and risk of
coronary heart disease (CHD) among men with type 2 diabetes.
BACKGROUND Type 2 diabetes is associated with an increased risk of CHD. Emerging evidence suggests that
moderate alcohol intake is associated with an important reduction in risk of CHD in
individuals with type 2 diabetes.
METHODS We studied 2,419 men who reported a diagnosis of diabetes at age 30 or older in the Health
Professionals’ Follow-up study (HPFS). During 11,411 person-years of follow-up after
diagnosis, we documented 150 new cases of CHD (81 nonfatal myocardial infarction [MI]
and 69 fatal CHD). Relative risks (RR) were estimated from pooled logistic regression
adjusting for potential confounders.
RESULTS Alcohol use was inversely associated with risk of CHD in men with type 2 diabetes. The
age-adjusted RRs corresponding to intakes of 0.5 drinks/day, 0.5 to 2 drinks/day and 2
drinks/day were 0.76 (95% confidence interval: [CI]: 0.52 to 1.12), 0.64 (95% CI: 0.40 to
1.02) and 0.59 (95% CI: 0.32 to 1.09), respectively, as compared with nondrinkers (p for
trend  0.06). When we controlled for body mass index, smoking, family history of MI,
hypertension, hypercholesterolemia, duration of diabetes, physical activity level, vitamin E
supplements and intake of trans fat, polyunsaturated fat, fiber and folate, RRs were 0.78 (95%
CI: 0.52 to 1.15), 0.62 (95% CI: 0.40 to 1.00) and 0.48 (95% CI: 0.25 to 0.94) (p for trend
0.03). The benefits of moderate consumption did not statistically differ by beverage type.
CONCLUSIONS Moderate alcohol consumption is associated with lower risk of CHD in men with type 2 diabetes.
(J Am Coll Cardiol 2001;38:1836–42) © 2001 by the American College of Cardiology
Atherosclerosis is the most frequent complication of type 2
diabetes and the underlying cause of death in approximately
80% of patients with diabetes (1). Insulin resistance, hyper-
tension, dyslipidemia, glucose intolerance, hyperinsulin-
emia, dysfibrinolysis and endothelial dysfunction may con-
tribute to the macrovascular complications of diabetes.
The association between moderate alcohol drinking and
coronary heart disease (CHD) in the general population is
well established (2). Four recent studies point to reductions
in CHD risk associated with moderate alcohol intake in
individuals with type 2 diabetes (3–6). However, the im-
portance of beverage type and the influence of possible
confounders like diet, obesity or concurrent health condi-
tions have not been adequately addressed. This study
investigated the association between alcohol consumption
and CHD among men with type 2 diabetes in the Health
Professionals’ Follow-up study (HPFS).
METHODS
The HPFS study is a prospective cohort study of 51,529
men aged 40 to 75 in 1986. The current study included
2,419 men who reported a physician’s diagnosis of diabetes
mellitus at the age of 30 or older on any questionnaire from
1986 through 1994. Men who reported a diagnosis of
diabetes were mailed a supplementary questionnaire that
included ascertained prediagnostic symptoms, clinical test-
ing that led to diagnosis and current treatment regimen.
Cases were considered confirmed if any of the following
were met: one or more classic symptoms plus a raised fasting
(7.8 mmol/l) or random (11.1 mmol/l) plasma glucose
concentration; at least two raised plasma glucose concentra-
tions on separate occasions (fasting, 7.8 mmol/l or ran-
dom, 11.1 mmol/l, or 11.1 mmol/l after 2 h or more on
glucose tolerance testing) in the absence of symptoms;
treatment with a hypoglycemic drug: insulin or oral hypo-
glycemic agent (7). Because the cases of diabetes for this
analysis were diagnosed before 1994, we used the diagnostic
criteria in place for that time period and not the more recent
classifications (8). Validity of self-reported diabetes was
verified in a subsample of 71 men from the HPFS cohort.
Of these, 12 had incomplete records while the diagnosis of
type 2 diabetes was confirmed in 57 (97%) of the remaining 59.
Alcohol use. Average daily consumption of beer, wine and
spirits was included in the semiquantitative food frequency
questionnaire in 1986, 1990 and 1994. For each beverage, a
commonly used portion size was specified, and the partici-
pants were asked how often, on average, over the past year
they consumed that amount. Standard portion sizes were
specified as a can/bottle or glass for beer, 4-oz glass for wine
and one drink or shot for liquor. A previous study found this
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questionnaire to measure alcohol intake with a high degree
of validity (9). The intake derived from the questionnaire
and that from multiple week diet records were highly
correlated (Spearman r  0.86), while mean intakes were
very similar. Also, serum high-density lipoprotein choles-
terol (HDL-C) levels were significantly correlated with
alcohol intakes estimated from the questionnaire among
men in the HPFS.
CHD end points. Fatal CHD and nonfatal myocardial
infarction (MI) occurring between the return of the 1986
questionnaire and 1996 were the end points of the analysis.
Self-reported MIs were confirmed by reviewing medical
records if they met World Health Organization criteria:
characteristic symptoms with either typical electrocardio-
graphic changes or elevations of cardiac enzymes. Probable
cases of MI (no available records but confirmation of
hospitalization and information from telephone interview/
letter representing 0.9% of cases) were also included in the
analysis after ensuring that results were not appreciably
different from the definite cases.
Deaths were reported by next of kin, work associates and
postal authorities. In case of persistent nonresponse, the
National Death Index was used to identify deceased cohort
members. Fatal CHD was confirmed by reviewing medical
records or autopsy reports with the permission of the next of
kin. The cause listed on the death certificate was not
sufficient alone to confirm a coronary death. Sudden deaths
(i.e., death within 1 h of symptom onset in a man without
known disease that could explain death) were included in
the fatal MI category. For subjects with multiple end points,
follow-up ended with onset of the first event.
Data analysis. Person-months of follow-up were accumu-
lated for patients with diabetes starting with the date of
return of the 1986 questionnaire for men diagnosed with
diabetes at enrollment or with the return of the question-
naire on which type 2 diabetes was first reported until the
occurrence of a CHD end point, death or January 31, 1996.
We excluded subjects with a history of CHD (MI, angina or
coronary revascularization), stroke or cancer reported at
baseline. Patients with a prior MI and cancer were subse-
quently excluded from analyses.
Men were divided into four categories of alcohol intake:
nondrinkers, 0.5 drinks/day, 0.5 to 2 drinks/day and 2
drinks/day. Relative risks (RR) were calculated as the CHD
incidence rate for a given category of alcohol intake com-
pared with the nondrinkers category. Tests for trend were
calculated by assigning the median value to increasing
categories of alcohol use. P values of less than 0.05 were
considered statistically significant. Relative risks were ini-
tially calculated adjusting for age. Multivariate logistic
regression was then used to estimate RRs of CHD over each
two-year follow-up interval using the alcohol intake re-
ported on the most recent questionnaire, adjusting for other
potential confounders: physical activity (quintiles of meta-
bolic equivalents spent weekly), body mass index (BMI)
(23 kg/m2, 23 to 24.9, 25 to 29.9, 30), smoking (never
smoker, 10, 10 to 24, 25 to 44, 45 to 64, 65 pack years),
history of hypertension, high cholesterol, family history of
MI, use of vitamin E supplements and dietary intake of
trans fat, polyunsaturated fat (percent of total energy in-
take), fiber, folate and total calories. We additionally con-
trolled for insulin and oral hypoglycemic drug use in
analyses on men with definite and symptomatic type 2
diabetes. Person-years with missing information for alcohol
intake due to an unreturned questionnaire were not consid-
ered in the analysis. Alcohol’s interaction with CHD risk
factors (smoking, BMI, hypertension, family history of MI
and hypercholesterolemia) were assessed by the likelihood
ratio statistic (difference in deviance or in 2 Log Likeli-
hood) between the model containing the interaction of
alcohol with each risk factor and the main effects model
following a chi square distribution with 2 degrees of
freedom.
RESULTS
Subjects with type 2 diabetes in the cohort had predomi-
nantly light-to-moderate intake of alcohol, with 39% of
person-time accounted for by men with no alcohol intake,
31% with 0.5 drink/day, 20% between 0.5 and 2 drinks/
day and only 10% drinking 2 alcoholic drinks/day. The
median intake in this highest category was 2.8 drinks/day.
Baseline characteristics of prevalent cases of diabetes are
shown in Table 1. Compared with the reference group
(nondrinkers), men who drank alcohol tended to have a
lower intake of fiber, a lower proportion of people with
family history of MI and a higher proportion of current
smokers, people with hypercholesterolemia and hyperten-
sives.
During 11,411 person-years of follow-up, we docu-
mented 150 new cases of CHD (81 nonfatal MI and 69 fatal
CHD). The age-adjusted rate RRs across categories of
alcohol consumption (0.5 drinks/day, 0.5 to 2 drinks/day
and 2 drinks/day) were 0.76 (95% confidence interval
[CI]: 0.52 to 1.12), 0.64 (95% CI: 0.40 to 1.02) and 0.59
(95% CI: 0.32 to 1.09), respectively, as compared with
nondrinkers (p for trend  0.06). This inverse association
became slightly stronger after adjusting for potential covari-
ates: 0.78 (95% CI: 0.52 to 1.15), 0.62 (95% CI: 0.40 to
Abbreviations and Acronyms
AGE  advanced glycation end products
BMI  body mass index
CHD  coronary heart disease
CI  confidence interval
HDL-C  high-density lipoprotein cholesterol
HPFS  Health Professionals’ Follow-up study
MI  myocardial infarction
PAI-1  plasminogen activator inhibitor 1
RR  relative risk
t-PA  tissue type plasminogen activator
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1.00), 0.48 (95% CI: 0.25 to 0.94) (p for trend  0.03)
(Table 2). To assess the effect of alcohol intake in different
subgroups of type 2 diabetics, data were stratified by
smoking status, BMI, presence of hypertension, family
history of MI and presence of hypercholesterolemia. The
inverse association was observed in all subgroups (Table 3).
Formal testing for interaction showed that family history of
MI marginally modified the effect of alcohol intake on
CHD risk (p  0.09). In further analyses, when nondrink-
ers without family history of MI were considered in the
reference group, men with a family history of MI had a risk
ratio for CHD of 3.13 (95% CI: 1.80 to 5.43) if they drank
no alcohol, of 1.71 (95% CI: 0.85 to 3.45) if they drank
0.5 drinks/day and 0.65 (95% CI: 0.23 to 1.84) if they had
an intake of more than 0.5 drinks/day. This interaction
awaits confirmation in other populations.
To determine if “sick quitters” were contributing to
higher rates of CHD among the abstainers, we conducted
analyses excluding 637 nondrinkers who reported a reduc-
tion in alcohol intake on the baseline questionnaire or who
had a lifetime exposure of more than 50 alcoholic drinks.
After exclusions, the multivariate RRs were 0.64 (95% CI:
0.36 to 1.15), 0.53 (95% CI: 0.28 to 1.00) and 0.42 (95%
CI: 0.18 to 0.95) for intakes of 0.5 drinks/day, 0.5 to 2
drinks/day and 2 drinks/day, respectively.
Intakes of beer, wine or liquor were each inversely
associated with CHD (Table 4). The multivariate RRs
corresponding to an intake of liquor of0.5 drinks/day and
greater than 0.5 drinks/day were 0.78 (95% CI: 0.52 to
1.16) and 0.48 (95% CI: 0.27 to 0.86) (p for trend  0.02).
The corresponding RRs for beer were 0.71 (95% CI: 0.48 to
1.04) and 0.48 (95% CI: 0.20 to 1.14) (p for trend  0.11)
Table 1. Age-Adjusted Baseline Characteristics Among Men With Type 2 Diabetes By Average
Alcohol Intake
Alcohol Intake (Drinks/Day)
Baseline Characteristics 0 0.1–0.5 0.51–2 >2
Age (yr) 60.2 60.1 60.1 60.5
Physical activity (METS/week) 19.3 18.5 18.5 23.8
BMI (kg/m2) 26.6 26.3 26.1 26.1
Current smoker (%) 8.2 10.4 12.0 19.8
Hypertension (%) 42.5 44.8 50.2 49.3
High cholesterol (%) 16.8 20.1 18.7 19.8
Family history of MI (%) 12.9 13.7 10.8 8.1
Vitamin E supplement use (%) 19.9 18.0 21.0 26.8
Total fat intake (% total kcals) 33.9 34.0 33.5 29.3
Polyunsaturated fat intake (% total kcals) 6.3 6.4 6.1 5.6
Saturated fat intake (% total kcals) 11.6 11.4 11.6 10.1
Dietary fiber (g/day) 23.5 22.4 20.8 19.8
BMI  body mass index; METS  metabolic equivalents; MI  myocardial infarction.
Table 2. Relative Risks (95% CI) for Total, Fatal and Nonfatal MI Associated With Alcohol
Consumption Among Men With Type 2 Diabetes (n  2,419) Enrolled in the Health
Professionals’ Follow-up Study (1986–1996)
Alcohol Intake (Drinks/Day)
None 0–0.5 0.5–2 >2 p Trend
Total MI
# cases 71 43 24 12
Person-years 4,374 3,549 2,306 1,182
Age-adjusted 1 0.76 (0.52, 1.12) 0.64 (0.40, 1.02) 0.59 (0.32, 1.09) 0.06
Multivariate* 1 0.78 (0.52, 1.15) 0.62 (0.38, 1.00) 0.48 (0.25, 0.94) 0.03
Nonfatal CHD
# cases 39 23 13 6
Person-years 4,374 3,549 2,306 1,182
Age-adjusted 1 0.74 (0.44, 1.25) 0.62 (0.33, 1.17) 0.53 (0.22, 1.27) 0.13
Multivariate* 1 0.78 (0.46, 1.33) 0.66 (0.34, 1.26) 0.56 (0.22, 1.41) 0.19
Fatal CHD
# cases 32 20 11 6
Person-years 4,374 3,549 2,306 1,182
Age-adjusted 1 0.79 (0.45, 1.39) 0.66 (0.33, 1.31) 0.66 (0.27, 1.59) 0.31
Multivariate* 1 0.79 (0.44, 1.41) 0.59 (0.29, 1.21) 0.45 (0.17, 1.14) 0.08
*Adjusted for physical activity (quintiles of metabolic equivalents spent weekly), body mass index (23, 23–24.9, 25–29.9,30),
smoking in packyears (never smoker, 10, 10–24, 25–44, 45–64, 65), presence of hypertension, high cholesterol, duration of
diabetes, family history of MI, vitamin E supplements and intake of fiber, folate, energy intake and percent calories from
polyunsaturated fat and trans fat.
CHD  coronary heart disease; CI  confidence interval; MI  myocardial infarction.
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and the RRs for wine were 0.70 (95% CI: 0.48 to 1.02) and
0.75 (95% CI: 0.37 to 1.52) (p for trend 0.34). The observed
effects did not statistically differ by beverage type.
When we examined rates of CHD within each category
of total alcohol consumption among nondiabetic men, the
age-adjusted incidence of MI was approximately 2.5 to 4.5
times less than that observed in type 2 diabetics. Alcohol
was associated with a greater absolute decrease in risk
subjects with type 2 diabetes than it was in nondiabetics.
Using the nondrinkers nondiabetics as a reference group, we
cross-classified men by their alcohol and diabetes status
(Fig. 1). In multivariate analyses, nondiabetics who drank
2 drinks/day had the lowest RR for CHD (RR  0.56,
95% CI: 0.44 to 0.70). Increasing consumption of alcohol
among subjects with diabetes decreased risk of CHD. At an
alcohol intake of 0.5 to 2 drinks/day and 2 drinks/day,
Table 3. Multivariate* RR (95% CI) of Total CHD Associated with Alcohol Consumption
Among Men With Type 2 Diabetes (n  2,419) Enrolled in the Health Professionals’ Follow-
up Study (1986–1996)
Alcohol Intake (Drinks/Day)
None 0–0.5 >0.5 p Trend p Interaction
Cigarette smoking
Yes 1 0.52 (0.09, 2.97) 0.33 (0.06, 1.91) 0.28 0.68
No 1 0.77 (0.52, 1.15) 0.58 (0.38, 0.91) 0.03
BMI
25 1 0.70 (0.36, 1.35) 0.43 (0.20, 0.94) 0.08 0.62
25 1 0.77 (0.47, 1.26) 0.64 (0.38, 1.09) 0.14
Hypertension
Yes 1 0.91 (0.56, 1.49) 0.57 (0.33, 0.98) 0.04 0.51
No 1 0.56 (0.28, 1.10) 0.59 (0.28, 1.22) 0.26
Family history of MI
Yes 1 0.46 (0.18, 1.14) 0.19 (0.06, 0.64) 0.01 0.09
No 1 0.85 (0.54, 1.33) 0.69 (0.43, 1.12) 0.15
Hypercholesterolemia
Yes 1 0.89 (0.47, 1.68) 0.63 (0.32, 1.26) 0.19 0.63
No 1 0.74 (0.44, 1.23) 0.52 (0.29, 0.92) 0.04
*Adjusted for physical activity (quintiles of metabolic equivalents spent weekly), body mass index (23, 23–24.9, 25–29.9,30),
smoking in packyears (never smoker, 10, 10–24, 25–44, 45–64, 65), presence of hypertension, high cholesterol, duration of
diabetes, family history of MI, vitamin E supplements, intake of fiber, folate, energy and percent calories from polyunsaturated
fat and trans fat.
BMI  body mass index; CHD  coronary heart disease; CI  confidence interval; MI  myocardial infarction; RR 
relative risk.
Table 4. Relative Risk (95% CI) of CHD by Types of Alcoholic Beverage Among Men With
Type 2 Diabetes (n  2,419)
Alcohol Intake (Drinks/Day)
None 0–0.5 >0.5 p Trend
Liquor
# cases 101 34 15
Person-years 6,786 2,942 1,683
Age-adjusted 1 0.78 (0.52, 1.15) 0.55 (0.32, 0.95) 0.03
Multivariate* 1 0.78 (0.52, 1.16) 0.48 (0.27, 0.86) 0.02
Multivariate  wine and beer 1 0.91 (0.58, 1.42) 0.55 (0.30, 1.01) 0.05
Beer
# cases 105 39 6
Person-years 7,041 3,672 699
Age-adjusted 1 0.71 (0.49, 1.03) 0.56 (0.25, 1.30) 0.18
Multivariate* 1 0.71 (0.48, 1.04) 0.48 (0.20, 1.14) 0.11
Multivariate  wine and liquor 0.84 (0.55, 1.31) 0.55 (0.23, 1.33) 0.20
Wine
# cases 99 42 9
Person-years 6,589 3,968 855
Age-adjusted 1 0.72 (0.50, 1.04) 0.74 (0.37, 1.47) 0.30
Multivariate* 1 0.70 (0.48, 1.02) 0.75 (0.37, 1.52) 0.34
Multivariate  beer and liquor 1 0.82 (0.54, 1.23) 0.91 (0.44, 1.88) 0.79
*Adjusted for physical activity (quintiles of metabolic equivalents spent weekly), body mass index (23, 23–24.9, 25–29.9,30),
smoking in packyears (never smoker, 10, 10–24, 25–44, 45–64, 65), presence of hypertension, high cholesterol, duration of
diabetes, family history of myocardial infarction, vitamin E supplements, intake of fiber, folate, energy and percent calories from
polyunsaturated fat and trans fat.
CHD  coronary heart disease; CI  confidence interval.
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subjects with diabetes did not have a significantly elevated
risk of CHD in comparison with nondiabetic nondrinkers
(RR 1.17, 95% CI: 0.79 to 1.74 and RR 1.14, 95% CI:
0.68 to 1.91, respectively).
DISCUSSION
Summary of findings, strengths and limitations. Moder-
ate alcohol intake was associated with a lower risk of CHD
in men with type 2 diabetes, beer, wine and liquor all
contributing to this association. The inverse association was
not confounded by other independent risk factors for CHD:
duration of diabetes, physical activity, BMI, current smok-
ing, presence of hypertension, high cholesterol, family
history of MI, vitamin E supplements and intakes of trans
fat, polyunsaturated fat, fiber and folate.
The prospective design reduces the potential for bias from
differential reporting of alcohol between cases and noncases.
Furthermore, the availability of updated measures of alcohol
intake and covariates over the follow-up period enabled us
to incorporate changes in lifestyle characteristics into the
analysis. One limitation of this study is the ascertainment of
diabetes status through self-report and the fact that some
cases may have been diagnosed during routine screening. To
determine if screening bias altered our results, we conducted
subanalyses of the main association among men who had
definite diabetes (n  1,513) as identified by responses on
the supplementary questionnaire and among men who had
diabetic symptoms at the time of diagnosis (n  942). The
multivariate RRs of CHD across categories of alcohol
consumption (0.5 drinks/day, 0.5 to 2 drinks/day and 2
drinks/day) were 0.72 (95% CI: 0.43 to 1.20), 0.43 (95% CI:
0.20 to 0.89), 0.38 (95% CI: 0.13 to 1.07) among the subset
of definite subjects with diabetes and 0.84 (95% CI: 0.45 to
1.56), 0.59 (95% CI: 0.24 to 1.45), 0.46 (95% CI: 0.11 to
2.01) among subjects with diabetes with symptoms at
diagnosis.
Previously, we found that alcohol intake was reported
with a high degree of validity as shown on a subsample of
this cohort (9). However, underreporting by some respon-
dents at the higher end of consumption may still have
occurred, in which case the range of benefit may be
somewhat underestimated.
Review of other epidemiologic studies. Our results are
consistent with those of the four recent studies that focused
on the effect of alcohol on occurrence of MI (4), cardiovas-
cular death (3,5) and both fatal and nonfatal CHD (6)
among patients with diabetes.
In a population of 983 men and women with type 2
diabetes aged 68.6  11.0 years in the Wisconsin Epide-
miologic Study of Diabetic Retinopathy, Valmadrid et al.
(3) found important reductions of mortality from CHD
among individuals consuming2, 2 to 13 and 14 g or more
alcohol/day, compared with never drinkers: 0.54 (95% CI:
0.33 to 0.90), 0.44 (95% CI: 0.23 to 0.84) and 0.21 (95%
CI: 0.09 to 0.48), respectively. Former drinkers’ risk of
death from CHD tended to be lower than that of never
drinkers, but this difference was not statistically significant.
The authors controlled for severity of diabetes using glyco-
sylated hemoglobin level and plasma C-peptide. After
controlling for HDL-C in a subgroup of 451 patients,
alcohol intake of more than 2 g/day was still significantly
associated with a lower risk of CHD, which suggests that
Figure 1. Multivariate* relative risks of coronary heart disease (CHD) and 95% confidence intervals according to levels of alcohol intake and diabetes status.
*Adjusted for physical activity (quintiles of metabolic equivalents spent weekly), body mass index (23, 23 to 24.9, 25 to 29.9, 30), smoking in pack years
(never smoker, 10, 10 to 24, 25 to 44, 45 to 64, 65), presence of hypertension, high cholesterol, family history of myocardial infarction, vitamin E
supplements and intake of fiber, folate, energy intake and percent calories from polyunsaturated fat and trans fat.
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additional cardioprotective mechanisms may be operating
(e.g., decreases in fibrinogen and increases in insulin sensi-
tivity).
In a study by Solomon et al. (4), 5,103 women in the
Nurses’ Health study who reported type 2 diabetes at age 30
or older were followed from 1980 to 1994. Risk ratios for
nonfatal or fatal CHD were 0.72 (95% CI: 0.54 to 0.96) and
0.45 (95% CI: 0.29 to 0.68) for those who reported 0.1 to
4.9 g alcohol/day and 5 g/day, respectively, compared
with nondrinkers.
Similarly, among 2,790 men in the Physicians’ study with
diabetes at baseline Ajani et al. (6) found risk reductions for
CHD death of 1.11 (95% CI: 0.66 to 1.89), 0.67 (95% CI:
0.42 to 1.07), 0.42 (95% CI: 0.23 to 0.77) (p for trend 
0.002) corresponding to alcohol levels of monthly, weekly
and daily as compared with rarely/never drinkers. In a
subsample of 510 diabetics followed for CHD incidence,
RR were 0.84 (95% CI: 0.46 to 1.54), 0.75 (95% CI: 0.45
to 1.26), 0.66 (95% CI: 0.38 to 1.16) for the same categories
of intake.
Among 133 male patients with diabetes in the World
Health Organization Multinational Study of Vascular Dis-
ease in Diabetes, Diem et al. (5) found a significant inverse
association (odds ratio  0.90, 95% CI: 0.81 to 1.0) for an
intake of 16 g to 30 g alcohol/day, compared with non-
drinkers. Lower and higher intakes were not associated with
reduced risk.
Potential mechanisms underlying the association. The
inverse association between alcohol and CHD, documented
in over 40 prospective studies of healthy populations, is
probably in large part achieved through the direct effects of
ethanol on increasing HDL-C (2,10). This mechanism may
be even more important among diabetics, as low levels of
HDL-C are a common feature of type 2 diabetes.
Diabetic hyperglycemia leads to oxidative stress in the
vessel wall through formation of advanced glycation end
products (AGE) and enhanced binding to the receptors for
AGE (11,12). Alcohol may lower the production of AGE
through its metabolite acetaldehyde (13).
Also, type 2 diabetes is associated with decreased fibri-
nolysis attributable to elevated concentrations of plasmino-
gen activator inhibitor 1 (PAI-1) (14). In vitro studies show
that alcohol downregulates the expression of the PAI-1
gene (15). In free living populations, alcohol may be
positively associated with plasma levels of the thrombolytic
tissue type plasminogen activator (t-PA), independent of
HDL-C levels (16). Additionally, platelet aggregation is
inhibited by ethanol (17,18), which may be particularly
important in patients with type 2 diabetes who are prone to
increased platelet aggregability. Finally, fibrinogen is in-
creased in type 2 diabetes (19), yet moderate alcohol
consumption is associated with lower levels of fibrinogen
(2,20).
The effects of moderate alcohol consumption on insulin
sensitivity may also partly explain the benefit we found.
Although increased insulin resistance is induced by heavy
drinking, light and moderate alcohol intake (1 to 3 drinks/
day) is associated with increased insulin sensitivity (21,22).
During prolonged fasting, alcohol may induce hypoglycemia
and hyperketonaemia (23), whereas, during the fed state,
alcohol may induce hyperglycemia (24). Despite these
possibilities, multiple studies show no alteration of glucose
homeostasis when moderate alcohol is consumed with meals
(25,26). It has also been shown that moderate alcohol
consumption is associated with decreased risk of diabetes
(27).
Risk and benefit of alcohol consumption among diabet-
ics. Although heavy drinking is associated with diabetic
neuropathy (28) and retinopathy (29), moderate alcohol
intake poses little, if any, additional risk for these compli-
cations (30,31). Other alcohol-related risks particularly
relevant for this population are hypertension and stroke.
Available data do not support an increased risk of hyper-
tension with moderate drinking in the general population
(32), and recent evidence suggests moderate drinking is
inversely associated with total stroke, mostly through reduc-
tions in the more common ischemic stroke (33,34).
The results of this study are consistent with previous
reports in other populations showing CHD risk reduction
due to light and moderate alcohol intake among patients
with type 2 diabetes. The risk reduction between drinkers
and nondrinkers was stronger among subjects with diabetes
than it was among nondiabetics in our population, albeit the
confidence intervals were larger. Nonetheless, recommend-
ing alcohol to abstainers is still controversial. The benefit of
reduced CHD needs to be weighed against the potential for
risk among populations consuming more than 1 drink/day.
In healthy populations, light-to-moderate alcohol intake is
associated with reduced total mortality (35,36). In our
sample of men with diabetes, the RRs of death from all
causes for intakes of 0.5 drinks/day, 0.5 to 2 drinks/day
and 2 drinks/day were 0.72 (95% CI: 0.54 to 0.97), 0.67
(95% CI: 0.47 to 0.95) and 0.62 (95% CI: 0.40 to 0.97) as
compared with nondrinkers. Also, the RRs for any cardio-
vascular death were 0.73 (95% CI: 0.48 to 1.11), 0.69 (95%
CI: 0.42 to 1.14) and 0.53 (95% CI: 0.27 to 1.05) for the
same categories of intake. It has been repeatedly shown that
people in these age groups are less likely than younger
individuals to abuse alcohol, binge drink or drive under its
influence (37). Light-to-moderate drinking with meals may
be an attractive and beneficial lifestyle component for the
patient with diabetes. Those with personal or family history
of abuse, intolerance, psychiatric problems, contraindica-
tions or other alcohol-related problems should certainly be
advised not to drink. It remains for the clinician to decide
whether to include alcohol recommendations as part of the
treatment plan for patients with type 2 diabetes. For most,
the benefits would likely outweigh the risks. Studies assess-
ing the effect of moderate alcohol intake on biological
markers associated with CHD in patients with diabetes
would help in generating recommendations to be included
in diabetes treatment guidelines.
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